These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 10513686)

  • 1. Platelet count and function in children receiving sodium valproate.
    Verrotti A; Greco R; Matera V; Altobelli E; Morgese G; Chiarelli F
    Pediatr Neurol; 1999 Sep; 21(3):611-4. PubMed ID: 10513686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Valproate-mediated disturbances of hemostasis: relationship to dose and plasma concentration.
    Gidal B; Spencer N; Maly M; Pitterle M; Williams E; Collins M; Jones J
    Neurology; 1994 Aug; 44(8):1418-22. PubMed ID: 8058141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombocytopenia during valproic acid treatment in young patients with new-onset bipolar disorder.
    De Berardis D; Campanella D; Matera V; Gambi F; La Rovere R; Sepede G; Grimaldi MR; Pacilli AM; Salerno RM; Ferro FM
    J Clin Psychopharmacol; 2003 Oct; 23(5):451-8. PubMed ID: 14520121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of chronic administration of valproic acid to epileptic patients on coagulation tests and primary hemostasis.
    Zighetti ML; Fontana G; Lussana F; Chiesa V; Vignoli A; Canevini MP; Cattaneo M
    Epilepsia; 2015 May; 56(5):e49-52. PubMed ID: 25757394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Valproate-induced thrombocytopenia: a prospective monotherapy study.
    Nasreddine W; Beydoun A
    Epilepsia; 2008 Mar; 49(3):438-45. PubMed ID: 18031547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Valproic-acid-induced thrombocytopenia and hepatotoxicity: discontinuation of treatment?
    Lackmann GM
    Pharmacology; 2004 Feb; 70(2):57-8. PubMed ID: 14685007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Valproate treatment and platelet function: the role of arachidonate metabolites.
    Kis B; Szupera Z; Mezei Z; Gecse A; Telegdy G; Vécsei L
    Epilepsia; 1999 Mar; 40(3):307-10. PubMed ID: 10080510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Valproic acid and thrombocytopenia in children: a case-controlled retrospective study.
    Allarakhia IN; Garofalo EA; Komarynski MA; Robertson PL
    Pediatr Neurol; 1996 May; 14(4):303-7. PubMed ID: 8805173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased platelet count in children with epilepsy treated with valproate and its relationship to the immature platelet fraction.
    Kurahashi H; Takami A; Murotani K; Numoto S; Okumura A
    Int J Hematol; 2018 Jan; 107(1):105-111. PubMed ID: 28879549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The platelet aggregation in children with epilepsy receiving valproic acid.
    Tanindi S; Akin R; Koseoglu V; Kurekci AE; Gokcay E; Ozcan O
    Thromb Res; 1996 Feb; 81(4):471-6. PubMed ID: 8907296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Severe, isolated thrombocytopenia under polytherapy with carbamazepine and valproate.
    Finsterer J; Pelzl G; Hess B
    Psychiatry Clin Neurosci; 2001 Aug; 55(4):423-6. PubMed ID: 11442896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Platelet dysfunction in children during treatment with sodium valproate].
    Ikeda N; Mitsudome A; Ogata H; Ohfu M
    No To Hattatsu; 1984 Jan; 16(1):27-31. PubMed ID: 6424693
    [No Abstract]   [Full Text] [Related]  

  • 13. Haematological side effects of antiepileptic drug treatment in patients with epilepsy.
    Bachmann T; Bertheussen KH; Svalheim S; Rauchenzauner M; Luef G; Gjerstad L; Taubøll E
    Acta Neurol Scand Suppl; 2011; (191):23-7. PubMed ID: 21711253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of low-dose aspirin and specific thromboxane synthetase inhibition on whole blood platelet aggregation and adenosine triphosphate secretion in healthy dogs.
    Grauer GF; Rose BJ; Toolan L; Thrall MA; Colgan SP
    Am J Vet Res; 1992 Sep; 53(9):1631-5. PubMed ID: 1416368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High incidence of vaproate-induced coagulation disorders in children receiving valproic acid: a prospective study.
    Koenig S; Gerstner T; Keller A; Teich M; Longin E; Dempfle CE
    Blood Coagul Fibrinolysis; 2008 Jul; 19(5):375-82. PubMed ID: 18600085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hematologic manifestations and impaired liver synthetic function during valproate monotherapy.
    Hauser E; Seidl R; Freilinger M; Male C; Herkner K
    Brain Dev; 1996; 18(2):105-9. PubMed ID: 8733899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pro- and anticoagulatory factors under sodium valproate-therapy in children.
    Banerjea MC; Diener W; Kutschke G; Schneble HJ; Korinthenberg R; Sutor AH
    Neuropediatrics; 2002 Aug; 33(4):215-20. PubMed ID: 12368993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abciximab treatment in vitro after aspirin treatment in vivo has additive effects on platelet aggregation, ATP release, and P-selectin expression.
    Scazziota A; Altman R; Rouvier J; Gonzalez C; Ahmed Z; Jeske WP; Walenga JM; Fareed J
    Thromb Res; 2000 Dec; 100(6):479-88. PubMed ID: 11152927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Valproic acid and thrombocytopenia: cross-sectional study.
    Ko CH; Kong CK; Tse PW
    Hong Kong Med J; 2001 Mar; 7(1):15-21. PubMed ID: 11406671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carnitine Deficiency in Chinese Children with Epilepsy on Valproate Monotherapy.
    Qiliang L; Wenqi S; Hong J
    Indian Pediatr; 2018 Mar; 55(3):222-224. PubMed ID: 29629695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.